Acción Cambio Fecha
AbbVie USD 5.31B 178M 2026-09
Abbott USD 7.34B 22M 2026-09
Amgen USD 6.39B 169M 2026-09
AstraZeneca USD 6.93B 362M 2026-06
BioCryst Pharmaceuticals USD 13.74M 7.68M 2026-09
Bristol-Myers Squibb USD 2.7B 33M 2026-09
Eli Lilly USD 18.19B 1.4B 2026-09
GlaxoSmithKline GBP 6.28B 125M 2026-06
Incyte USD 134.25M 21.71M 2026-09
J&J USD 15.38B 233M 2026-09
Karyopharm Therapeutics USD 4.04M 72K 2025-12
MacroGenics USD 9.5M 1.59M 2026-03
Merck USD 6.16B 43M 2026-09
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Novartis USD 6.1B 116M 2026-09
Novartis USD 6.1B 182M 2026-09
Pfizer USD 10.02B 77M 2026-09
Regeneron Pharmaceuticals USD 2.89B 189.7M 2026-09
Roche Holding CHF 7.6B 9M 2025-06
Takeda JPY 1.44T 6.17B 2026-09
TG Therapeutics USD 194.32M 46.35M 2026-09
Ultragenyx Pharmaceutical USD 59M 0 2026-09